A fungal form of meningitis leads to more than 600,000 deaths in Africa every year and is responsible for 20 percent of HIV/AIDS-related deaths globally, according to the US Centers for Disease Control and Prevention. An existing medicine could help curb these numbers, but its cost has been a barrier to access in some places. Now, scientists report a more affordable way to make the drug.